Alaunos Therapeutics, Inc. Common Stock

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion. C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim, Inc. (NASDAQ: MINM) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim. Clearmind Medicine Inc. (NASDAQ: CMND) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity. FibroBiologics, Inc. (NASDAQ: FBLG) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ. Celularity Inc. (NASDAQ: CELU) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million. Cimpress plc (NASDAQ: CMPR) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares. TuSimple Holdings Inc. (NASDAQ: TSP) rose 28% to $0.2950. Elevai Labs, Inc. (NASDAQ: ELAB) gained 23.5% to $0.84 after gaining 8% on Wednesday. Asset Entities Inc. (NASDAQ: ASST) climbed 22.8% to $0.5650. Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS. Nextracker Inc. (NASDAQ: NXT) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results. SunPower Corporation (NASDAQ: SPWR) jumped 18.1% to $3.5791. BioRestorative Therapies, Inc. (NASDAQ: BRTX) gained 16.4% to $1.8850. Corteva, Inc. (NYSE:

Related tickers: BOOT, VLCN, MKL, CMPR, KPRX, SBH, ETSY, AEY, TCRT, SNY, RACE, CACC, PSNY, TSP, ASST, CHRW, YOSH, VLY, CMND, DGII, ELWS, WAL, REVB, EGHT, BFRG, MXL, PTON, FCEL, HSAI, NXT, CTVA, PLUG, ELAB, THR, ALGM, SRDX, FBLG, NVIV, SPWR, MINM, WOLF, BRTX, EVAX, ZION, EVER, IFBD, AFL, NRBO, CMAX, DB, NYCB, CELU, IHS, OGEN, RKLB, ING.

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street's estimate of $134.37 million. WD-40 shares jumped 17.3% to $277.56 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Nauticus Robotics, Inc. (NASDAQ: KITT) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO. Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder. Sana Biotechnology, Inc. (NASDAQ: SANA) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262. Ucommune International Ltd (NASDAQ: UK) jumped 37.8% to $4.98. Vicarious Surgical Inc. (NASDAQ: RBOT) rose 37% to $0.6851. Nvni Group Limited (NASDAQ: NVNI) climbed 35.2% to $2.6091. EchoStar Corporation (NASDAQ: SATS) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation. Amarin Corporation plc (NASDAQ: AMRN) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues. Exicure, Inc. (NASDAQ: XCUR) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin ...

Related tickers: TGTX, AIMD, EXAI, DCGO, UP, SIDU, SAR, ACRS, TCRT, SGH, NVCR, WLDS, AEHR, ICCT, KITT, AMRN, CMND, HOLO, ISRG, EAF, NAMS, MDRX, XCUR, NVNI, PRST, XERS, HWH, PSMT, GRTX, ROMA, GDRX, SATS, ETWO, WDFC, SANA, AZZ, NEXI, SSL, RBOT, UK.